These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20963906)

  • 21. Evaluation of circulating tumour cells expressing CD44 variants in the blood of gastric cancer patients by flow cytometry.
    Pituch-Noworolska A; Wieckiewicz J; Krzeszowiak A; Stachura J; Ruggiero I; Gawlicka M; Szczepanik A; Karcz D; Popiela T; Zembala M
    Anticancer Res; 1998; 18(5B):3747-52. PubMed ID: 9854488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of the tumor marker TAG-72 in head and neck neoplasms].
    Altissimi G; von Garrel C
    HNO; 1990 Oct; 38(10):364-6. PubMed ID: 2283330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary data.
    Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
    J Nucl Med Allied Sci; 1989; 33(1):32-6. PubMed ID: 2746365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The pre- and postoperative and follow-up use of the tumor markers MCA, CA-125 and CA-19-9].
    Zanon C; Alluminio P; Margarita V; Sottimano C; Giuliani F; Neri G; Ballario F
    Minerva Chir; 1992 Jan; 47(1-2):27-30. PubMed ID: 1553049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor associated glycoprotein (TAG 72) in gastric cancer.
    Lotzniker M; Pavesi F; Scarabelli M; Visconti GL; Bacchella L; Gini R; Moratti R
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):111-4. PubMed ID: 2092103
    [No Abstract]   [Full Text] [Related]  

  • 27. [Levels of circulating tumor-associated glycoprotein (TAG-72) in patients with carcinoma using a novel tumor marker, CA 72-4].
    Ohuchi N; Matoba N; Taira Y; Takahashi K; Sakai N; Sato K; Fujita N; Mochizuki F; Nishihira T; Mori S
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2767-72. PubMed ID: 3166366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
    Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tag 72: a new tumor-associated antigen identified by a monoclonal antibody].
    Piantino P; Fusaro A; Daziano E; Polloni R; Mosso R; Cacace G
    Minerva Med; 1990 Nov; 81(11):765-7. PubMed ID: 2255410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum ferritin and trophoblastic globulin in genital tumors in women].
    Griaznova IM; Borisenko SA; Markarov OV; Fomina MB; Prokopenko PG; Tatarinov IuS
    Vopr Onkol; 1990; 36(2):181-7. PubMed ID: 2180208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical usefulness of tumor markers for the diagnosis of ovarian cancer].
    Ito K; Udagawa Y; Nozawa S
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1964-70. PubMed ID: 1417005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9].
    Takahashi Y; Mai M
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary].
    Gadducci A; Bartolini T; Ferdeghini M; Facchini V; Bianchi R; Fioretti P
    Minerva Ginecol; 1987 Sep; 39(9):601-6. PubMed ID: 3479708
    [No Abstract]   [Full Text] [Related]  

  • 34. Granulocyte colony stimulating factor-producing collision tumor of the gastric cardia.
    Komatsu D; Sakurai M; Nakafuji H; Koide N; Morishita H; Nakamura T
    J Gastroenterol; 2003; 38(10):1013-5. PubMed ID: 14614613
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix].
    Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
    Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):625-9. PubMed ID: 2777050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A
    Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tumor marker squamous cell carcinoma antigen].
    Lavie O; Neuman M; Zuckerman B; Hornreich G; Beller U
    Harefuah; 1998 Sep; 135(5-6):222-5. PubMed ID: 9885641
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D; Hirasawa A; Susumu N
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The significance of pepsinogen with its subgroup and CA72-4 associate detect applied to early diagnostic and prognosis judgment on gastric cancer].
    Lin HZ; Chen L; Li XC; Zhou DF; Cui JY
    Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(24):1505-8. PubMed ID: 15733483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case control study of glycoprotein status in ovarian carcinoma.
    Aranganathan S; Senthil K; Nalini N
    Clin Biochem; 2005 Jun; 38(6):535-9. PubMed ID: 15885233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.